MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
Francesca De VitoAlessandra MusellaDiego FresegnaFrancesca Romana RizzoAntonietta GentileMario Stampanoni BassiLuana GilioFabio ButtariClaudio ProcacciniAlessandra ColamatteoSilvia BullittaLivia GuadalupiSilvia CaioliValentina VanniSara BallettaKrizia SannaAntonio BrunoEttore DolcettiRoberto FurlanAnnamaria FinardiValerio LicursiJelena DrulovicTatjana PekmezovicClorinda FuscoSara BruzzanitiEran HornsteinAntonio UccelliMarco SalvettiGiuseppe MatareseDiego CentonzeGeorgia MandolesiPublished in: Neuropathology and applied neurobiology (2021)
MiR-142-3p is a novel and potential negative prognostic CSF marker of MS and a promising tool for identifying personalised therapies.